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Apolipoprotein E (ApoE), an important mediator of lipid transportation in plasma and
the nervous system, plays a large role in diseases such as atherosclerosis and
Alzheimer’s. The major allele variants ApoE3 and ApoE4 differ only by one amino acid.
However, this difference has major consequences for the physiological behaviour of each
variant. In this paper, we follow (i) the initial interaction of lipid-free ApoE variants with
model membranes as a function of lipid saturation, (ii) the formation of reconstituted
High-Density Lipoprotein-like particles (rHDL) and their structural characterisation, and
(iii) the rHDL ability to exchange lipids with model membranes made of saturated lipids in
the presence and absence of cholesterol [1,2-dimyristoyl-sn-glycero-3-phosphocholine
(DMPC) or 1-palmitoyl-2-oleoyl-glycero-3-phosphocholine (POPC) with and without 20
mol% cholesterol]. Our neutron reflection results demonstrate that the protein variants
interact differently with the model membranes, adopting different protein conformations.
Moreover, the ApoE3 structure at the model membrane is sensitive to the level of
lipid unsaturation. Small-angle neutron scattering shows that the ApoE containing lipid
particles form elliptical disc-like structures, similar in shape but larger than nascent
or discoidal HDL based on Apolipoprotein A1 (ApoA1). Neutron reflection shows that
ApoE-rHDL do not remove cholesterol but rather exchange saturated lipids, as occurs
in the brain. In contrast, ApoA1-containing particles remove and exchange lipids to a
greater extent as occurs elsewhere in the body.
Keywords: ApoE isoforms, lipid exchange, reconstituted HDL, model membranes, neutron reflection, small-angle
neutron scattering
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INTRODUCTION
Disorders in lipid metabolism are related to a range of diseases,
among them atherosclerosis and Alzheimer’s disease (AD). In
atherosclerosis, the leading cause of death in western society,
elevated levels of high-density lipoproteins (HDL) are thought
to have counter-atherosclerotic properties (Gordon et al., 1989).
However, the presence of HDL has more recently been shown to
play a neutral (Voight et al., 2012) or even negative (Madsen et al.,
2017) role in aiding the prevention of this disease. Even though
HDL has been used to help combat the onset of atherosclerosis
(via HDL therapy or plaque remodelling therapy) (Gille et al.,
2014; Van Capelleveen et al., 2014), some recent medical trials
have failed to prove HDL’s effectiveness against atherosclerosis
(Angeloni et al., 2013; Toth et al., 2013).
In general, HDL consist of a core of triglycerides and
cholesterol esters, encased in a monolayer of lipids and
cholesterol, surrounded by protein. There are many different
subclasses of HDL each with slightly varying size and
composition (Jonas, 2002). In particular, the lipid-poor, nascent
HDL (also known as Preβ-HDL) is thought to be discoidal in
shape and transforms into a spherical, mature HDL particle
upon esterification of cholesterol and transfer into its lipid core.
While ApolipoproteinA1 (ApoA1) constitutes around 70% of
total protein content in human HDL, there are various other
proteins which are also key to the structure and function of HDL
particles (Jonas, 2002). One of these is ApolipoproteinE (ApoE)
(Utermann, 1975) which is found in most HDL subfractions but
mainly in the largest, most buoyant mature subfraction (HDL2)
that contains triglycerides and are lipid rich (Davidson et al.,
2009). ApoE is also the most commonly found apolipoprotein
in cerebrospinal fluid (Ladu et al., 2009). It plays a large role
in cholesterol transport while maintaining local homeostasis of
cholesterol within the brain (Mahley, 2016b).
In humans, ApoE allelic variants result in three isoforms
E2, E3, and E4, with respective frequencies of 8.4, 77.9, and
13.7% and varying at only two amino acid residues, 112 and
158 (E2: 112Cys, 158Cys; E3: 112Cys, 158Arg; E4: 112Arg,
158Arg) (Weisgraber et al., 1981). These differences in the amino
acid sequence largely contribute to the proteins’ structure and
function and determine their behaviour in the body (Chou
et al., 2005; Mahley et al., 2009), and especially in the roles
they play in certain diseases such as atherosclerosis and AD.
The presence of ApoE2 is associated with very low risk of
AD (Wu and Zhao, 2016; Reiman et al., 2020) and generally
thought to be protective against atherosclerosis, apart from in
the case of type III hyperlipoproteinemia which is associated
with increased atherosclerotic risk. On the other hand, ApoE3
levels are neutral in both diseases while the presence of ApoE4
is indicative of both atherosclerotic advancement and the onset
of AD (Mahley et al., 2009).
Lipids are important to these diseases as they coexist in both
atherosclerotic and AD plaques (Kiskis et al., 2015; Sergin et al.,
2016). Understanding the difference in the interaction of ApoE
variants with model cellular membranes is key to deciphering
the specific roles they play in the development of these diseases.
The roles of lipoproteins in the development of atherosclerosis
and, most likely in AD, directly involve lipid exchange. The type
of lipid exchange occurring— namely deposition or removal—
highly depends on the lipoprotein type present (Browning et al.,
2017). Previously, HDL was shown to remove lipids from the
cell membrane giving rise to the idea behind HDL therapy.
Reconstituted HDL (rHDL), comparable to discoidal Preβ-HDL,
exhibits similar lipid transfer properties to that of mature HDL
(Davidson et al., 1995), and is used to mimic this, discoidal
nanoparticles of phospholipids solubilised by encircling ApoA1
are used as artificial HDL or rHDL as a strategy in HDL therapy
(Gille et al., 2014; Van Capelleveen et al., 2014). While less
is known about the lipid exchange properties of ApoE, ApoE-
containing rHDL (ApoE-rHDL) were shown to have potential for
atherosclerosis treatment (Valanti et al., 2018), although further
testing is needed.
In this paper, the initial interaction of ApoE3 and ApoE4
with saturated and unsaturated supported lipid bilayers (SLBs)
is explored using neutron reflectometry (NR). Then, ApoE-
rHDL are formed based on the vesicle solubilisation method
often used to make ApoA1-rHDL. The ApoE-rHDL structure
is further characterised using small angle neutron scattering
(SANS). Finally, the lipid exchange capacity for ApoE-rHDLwith
model membranes is explored by NR. As ApoE is the main
apolipoprotein in the brain, where there is a local homeostasis
of cholesterol, the model membranes in question are in the
absence or presence of cholesterol to determine the potential
differences between these interactions. Comparisons are made
between to ApoA1-based rHDL and mature HDL pooled from
three healthy male volunteers [mature HDL is replotted from
Waldie et al. (2020)].
MATERIALS AND METHODS
Materials
MilliQ water (18.2 M cm) was used for all experiments,
solvent preparations and cleaning procedures. D2O (99.9%
deuterated, Sigma-Aldrich) was provided by the Institut Laue-
Langevin (ILL), Grenoble, France. Bradford reagent, calcium
chloride (CaCl2) and Tris buffer saline (TBS) tablets were
from Sigma-Aldrich. Tris buffer (50mM Tris, 150mM NaCl,
pH 7.4: TBS) was prepared by dissolving a tablet in H2O as
specified by the producer or D2O to the same concentration.
1,2-dimyristoyl-sn-glycero-3-phosphocholine (>99%, hDMPC),
1,2-dimyristoyl-d54-sn-glycero-3-phosphocholine (>99%,
dDMPC) and cholesterol (h-cholesterol; >98%) were from
Avanti Polar Lipids (Alabaster, AL). Tail deuterated 1-palmitoyl,
2-oleoyl-sn-glycero-3-phosphocholine (d67; overall tail
deuteration 95%, dPOPC) was provided by the deuteration
facility at ANSTO, produced and purified as previously described
(Yepuri et al., 2016).
Protein Expression and Purification
BL21DE3 Escherichia coli cells were transformed with pET-
32a(+) plasmids containing either ApoE3 or ApoE4 and
ampicillin resistance. Cells were cultivated in Terrific Broth
medium (12 g L–1 tryptone, 24 g L–1 yeast extract, 4mL
L–1 glycerol, 9.4 g L–1 dipotassium phosphate and 2.2 g L–1
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potassium dihydrogen phosphate) at 37◦C. When cultures
reached an OD600 nm of 0.6–0.8, protein expression was induced
by adding 1mM isopropyl-beta-thiogalactopyranoside (IPTG)
in the culture medium and incubated for a further 90min.
The cells were then harvested by centrifugation (19,000 rpm,
JLA 9.1000 rotor 20min, 4◦C) after which the cell pellets were
resuspended in TBS buffer and sonicated on ice for 10min (50%
power, 30 s on, 30 s off). hDMPC was suspended in water by
bath sonication for 30min and then added to the protein at a
concentration of 100mg per 1 L of culture and dialysed against
TBS at room temperature overnight. The hDMPC is added to
protect the hinge region of ApoE when cleaving with thrombin.
After dialysis, thrombin was added in excess for 6 h at 37◦C. The
sample was analysed by SDS-PAGE to ensure all fusion protein
had been cleaved. Potassium bromide was added to the ApoE-
DMPC mixture to a density of ∼1.21 g mL–1. Ultra-clear tubes
(Beckman) were filled two-thirds with a ∼1.12 g mL–1 density
solution (16% w/v potassium bromide solution dissolved in
20mM Tris pH 7.4 and 0.05% w/v sodium azide) and underlayed
with the lysate solution. Samples were spun for 16 h at 38,000 rpm
in a SW41 rotor (Beckman) at 15◦Cwith the break off to preserve
the gradient. The resulting “floating pellet” was recovered and
dialysed against TBS to remove the potassium bromide salts.
The ApoE-DMPC complexes were lyophilised and frozen at
−20◦C. When fresh protein was required the pellets were
delipidated against methanol and resuspended in 6M Guanidine
Hydrochloride (GuHCl) 50mM Tris pH 8 and 0.5% beta-
mercaptoethanol (BME), dialysed against 4M GuHCl, 10mM
Tris pH 7.5, 1mMEDTA, and 0.1%BME; further against 100mM
ammonium bicarbonate; and finally into TBS. The protein was
then purified via gel-permeation column chromatography on 2
S200 columns in series and ready to use.
Protein-Lipid Particle Production and
Purification
To form the ApoE-rHDL particles, equal volumes of fresh protein
are mixed with freshly extruded hDMPC vesicles at a final molar
ratio of 1:100 ApoE:DMPC. The hDMPC vesicles were produced
by first forming a thin lipid film (in small vials, under nitrogen
flow under manual rotation) that was suspended in TBS first by
vortexing, then by bath sonication for 1 h. The lipid suspension
was extruded 41 times using an Avanti extruder and a filter of
100 nm pore size (Millipore). The solution was incubated at 24◦C
for 12 h or overnight. Verification of the particle formation was
carried out via dynamic light scattering due to a slight reduction
in the peak intensity for the 100 nm vesicles and the presence
of a small peak at roughly 10–15 nm. The rHDL particles were
purified via gel filtration chromatography using a Superose 6
10/300 column.
Deuterated Cholesterol Production
The production of tailor-deuterated cholesterol made use
of the Deuteration Laboratory within the Life Sciences
Group (Haertlein et al., 2016) at the ILL. Based on previous
developments for the production of perdeuterated cholesterol
(Moulin et al., 2018), matchout-deuterated cholesterol
(d-cholesterol) was produced and purified as reported
previously (Waldie et al., 2019). The Pichia pastoris strain
CBS7435 1his41ku70 1erg5::pPpGAP-ZeocinTM-[DHCR7]
1erg6::pGAP-G418[DHCR24] was grown in 100% deuterated
basal salts medium in the presence of non-deuterated glycerol
as the sole carbon source. The batch phase was complete after 7
days in a fermenter at 28◦C; the fed-batch phase was initiated by
constant feeding of glycerol for a further 12 days. The cells were
harvested and then isolated using an organic solvent extraction
method followed by HPLC to obtain pure cholesterol, verified
by GCMS.
Model Membrane Preparation
Lipid films were prepared in small glass vials from chloroform
stocks of dDMPC, dPOPC, h- and d-cholesterol. Twenty mol%
cholesterol was incorporated into the cholesterol-containing
films. The films were dried under a stream of nitrogen under
manual rotation, and placed under vacuum overnight. Before
use, the lipid films were hydrated in MilliQ water, vortexed
and bath sonicated for 1 h. Immediately prior to injection the
lipids were tip sonicated for 5min (20% power, 5 s on, 5 s off),
mixed with an equal volume of 4mM CaCl2 and injected into
the pre-equilibrated NR solid-liquid flow cells by a syringe port
(Browning et al., 2017;Waldie et al., 2019). The presence of 2mM
CaCl2 and concentration of 0.1mg mL–1 of lipids were used to
optimise vesicle fusion (Åkesson et al., 2012a;Waldie et al., 2018).
The lipids were incubated for 20min before rinsing with water,
followed by 50mM Tris saline buffer, pH 7.4. This process leads
to a supported lipid bilayer or “model membrane.”
Scattering
SANS and NR data were collected; scattered intensity and
reflectivity, respectively, were measured as a function of
momentum transfer, q = 4πsin(θ )/λ, where θ is half the
scattering angle for SANS and the incident angle for NR and λ
is the neutron radiation wavelength for both.
Neutron Reflectometry
Neutron reflectometry data were collected on the time-of-flight
reflectometer FIGARO (Campbell et al., 2011, 2015) at the ILL
(Grenoble, France). Momentum transfer ranges of 0.01 > q >
0.3 Å−1 were measured using wavelengths 2 < λ < 20 Å and
two incident angles, 0.8 and 2.3◦, with a spatial resolution (1q/q)
of 7%. The area exposed to the neutron beam was 30 × 60
mm2. The experiments were carried out in reflection-up mode
to ensure no aggregated particles could settle on the surface
being measured. The analysis of specular reflectivity data allowed
a scattering length density (SLD) profile perpendicular to the
surface, to be obtained.
The silicon (111) blocks were treated with Piranha solution
(H2SO4:H2O2, 7:3) for 10min at 80◦C before extensive rinsing
with MilliQ water (Warning: Piranha solution reacts violently
with organic materials and should be handled with extreme
caution). The polyether ether ketone (PEEK) and O-ring
components of the cells were thoroughly cleaned in Hellmanex
2% (v/v) solution and MilliQ water twice via bath sonication,
with rinsing of MilliQ water between each sonication. Solvent
contrasts were changed in situ via HPLC pump. Three isotopic
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contrasts were used: 100% h-TBS (TBS made using H2O), 100%
d-TBS (TBS made using D2O) and 38% d-TBS (or cmSi) to
contrast-match the silicon block.
The MOTOFIT programme (Nelson, 2006) was used
to simultaneously fit the three isotopic contrasts for each
experimental data set, and the Monte Carlo error analysis using
genetic optimisation within the software was used to determine
the error of the fits. The significance of pairwise parameters
were calculated using an F-test assuming normal distributed
errors. The clean silicon surfaces were characterised initially to
determine the thickness and roughness of the oxide layer. After
bilayer deposition, data was fitted using a symmetrical leaflet
model (heads-tails-heads) using either a four- or five-layer model
for the membranes since some samples required an extra solvent
layer between the silicon oxide and the bilayer. Symmetry implies
that the thickness, coverage and SLD of both headgroup layers are
the same, and the roughness was constrained across all regions of
the bilayer. The models were constrained to have the same mean
molecular area (MMA), within error, across the different lipid
bilayer layers. This fitting approach gives equivalent results to
the molecularly constrained model (for which MMA is used as a
fitting parameter instead). For example, POPC bilayers measured
at 25◦C were reported to be 62 Å2 (Luchini et al., 2019) and
62 Å2 (Åkesson et al., 2012a) fitting individual thicknesses or
MMA, respectively.
After bilayer characterisation, the ApoE protein or protein-
lipid particles were introduced into the solid-liquid flow cells
via syringe pump at a rate of 1mL min−1. The protein and
rHDL concentrations were 0.075mg mL−1 and 0.132mg mL−1,
respectively. After either 6 or 8 h of incubation, the bilayers were
rinsed with buffer and re-characterised in all buffer contrasts.
When fitting the bilayers post-interaction, the initial parameters
were used as a starting point (Table 1) while keeping constant
the silicon oxide layer parameters. For some bilayers, acceptable
fits were obtained by varying only the SLB coverage and lipid
tail SLD. For other bilayers, this approach gave no suitable fits
forcing the use of the thickness of these regions as an additional
fitting parameter. Moreover, an extra layer on top of the bilayer
was necessary in all cases corresponding to either the protein or
rHDL particles still attached to the bilayer.
Small-Angle Neutron Scattering
SANS data were collected on the D11 instrument at the ILL
(Lindner and Schweins, 2010). The experiments were carried out
at 25◦C with a momentum transfer range of 0.002 < q < 0.3
Å−1 by using detector distances of 1.4, 8, and 39m at constant
wavelength λ = 6 Å (fwhm 9%).
The protein-lipid particles were measured in three contrasts:
100% h-TBS, 100% d-TBS and 42% d-TBS to contrast-match
the protein. The data were corrected for the empty cell,
background and the absolute scale was obtained from the
attenuated direct beammeasurement and validated from the level
of water (1mm, H2O), used as a secondary standard. The cells
were 1mm path-length QS quartz glass Hellma SANS cuvettes
(Hellma GmbH, Müllheim, Germany) and the data reduction
was carried out using LAMP. The SasView programme was used
to fit the experimental data1. The three contrasts were fitted
simultaneously to constrain the fit.
RESULTS
In this work, the overall journey of ApoE is followed from its
interactions with model membranes in the lipid-poor form, to
the formation of a nascent-like HDL particle, and finally to the
characterisation of the lipid exchange capacities for saturated
lipids in the presence or absence of 20 mol% cholesterol.
NR and SANS are ideal techniques for this task as they can
distinguish between deuterated and non-deuterated components.
Therefore, the use of deuteration in lipid-protein complexes
allows highlighting of specific components within the system,
together with the use of contrast variation (based on the different
content of D2O-based buffers, denoted as d-TBS) to visualise
the differences between the components (Clifton et al., 2020).
Here, the model cellular membranes are made up of tail-
deuterated lipids and, in some membranes, the presence of
non-deuterated or specifically matchout-deuterated cholesterol.
The matchout deuterated cholesterol allows no net coherent
scattering to be seen for this component in 100% D2O-based
buffer conditions. The protein and rHDL particles, instead,
are unlabelled. The differences between the components in the
membrane and the protein/rHDL allows NR to be used in
determining: (1) the level of protein incorporation or lipid
exchange, through the change in the scattering length density
(SLD) of the tail region, (2) the amount of lipids that were
removed and replaced by protein or solvent, through the
change in the solvent quantity in the tail region, and (3) the
amount of extra protein/rHDL bound on top of the model
membrane. During the kinetics of interaction, the samples were
measured in H2O-based buffer (100% h-TBS) as this gives the
best contrast against the deuterated membrane layer, while full
characterisation in three contrasts (100% h-TBS, 100% d-TBS
and 38% d-TBS) of the model membranes before and after
kinetics were measured to increase the sensitivity and accuracy
of the structural and compositional information obtained. The
layer models describing the model membranes are determined
from simultaneous fitting of the isotopic contrasts and allow for
the analysis of the membrane composition and the decoupling of
the information regarding protein incorporation/lipid exchange
and lipid removal as described in the methods section
and the Supporting Information. Figure 1 gives schematic
representations of protein and nanodisc interactions with the
bilayers. Representative structural parameters for the pristine
SLBs are summarised in Table 1 and are in agreement with
those reported in the literature for DMPC (Browning et al.,
2018), POPC (Åkesson et al., 2012b; Waldie et al., 2020), 20
mol% cholesterol containing DMPC and POPC measured at
37◦C (MMA increases with temperature and the reported values
cannot be compared to MMA measured at 25◦C (Åkesson et al.,
2012a). POPC is fond to adopt a thicker, more expanded SLB
structure than DMPC given its longer tail and the presence of
double bonds that bend the acyl tails. Here, the thickening and
1http://www.sasview.org/.
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TABLE 1 | Representative structural parameters for the SLB used.
Head group thickness/ Tail thickness/ Headgroup coverage / % Tail coverage / % Mean molecular area / Å2
Å Å
dDMPC 9.0 ± 0.1 27.2 ± 0.2 62 ± 1 96 ± 1 59 ± 2
dPOPC 8.8 ± 0.2 28.6 ± 0.4 54 ± 2 86 ± 1 71 ± 5
dDMPC d-cholesterol* 8.5 ± 0.2 32.1 ± 0.2 71 ± 1 98 ± 1 52 ± 4
dDMPC h-cholesterol* 7.7 ± 0.4 30.7 ± 0.5 85 ± 5 94 ± 1 51 ± 4
Corresponding NR profiles and best fits are given in the Supplementary Information.
*The model membranes containing cholesterol had a nominal composition of 80:20mol %, and its real cholesterol content was determined to be the nominal one within error (Waldie
et al., 2018). d- and h- cholesterol refer to deuterated and hydrogenated cholesterol respectively.
FIGURE 1 | Schematic representation of protein incorporation into the phospholipid bilayer (A). NR cannot distinguish between the conformation of the protein upon
binding to the model membrane: whether there are two individual protein molecules adsorbing either in the core or the headgroup region vs. a single individual protein
molecule bending across the membrane (B). Schematic representation for lipid exchange between the rHDL and the phospholipid bilayer (C). Lipid exchange
represents the combination of lipid removal from the model membrane and lipid deposited by the rHDL particles (D). The light grey colour represents deuterated lipids
while the black colour represents non-deuterated lipids. Both DMPC and POPC lipids were used above their melting temperature, giving fluid supported lipid bilayers.
Addition of 20 mol% cholesterol to either POPC or DMPC give SLBs with fluid properties (Waldie et al., 2020).
compacting effect of cholesterol on fluid membranes is observed
in agreement with previous reports (Gallová et al., 2004; Hung
et al., 2007; Waldie et al., 2018, 2019). Moreover, the cholesterol
molecules are expected to be fully miscible within these model
membranes (Knoll et al., 1985; Barrett et al., 2013).
The samples measured by SANS (all unlabelled) were
measured in three contrasts: 100% h-TBS, 100% d-TBS
and 42% d-TBS. The different buffers used give varying
levels of isotopic contrast; for example, the 42% d-TBS
and 100% h-TBS highlight the lipids and the proteins
respectively, whereas the 100% d-TBS buffer gives the largest
contrast against the sample as a whole. Analysing all three
contrasts simultaneously allows for higher sensitivity in the
structural determination.
Initial Apolipoprotein Interaction With
Model Membranes
The binding of ApoE3 or ApoE4 tomodel membranes comprised
of saturated or unsaturated phospholipids was followed by NR
as a function of the saturation level in the bilayer at 37◦C in
Tris buffer, pH 7.4 (Figure 2). For this, we used saturated, tail
deuterated dDMPC and unsaturated, tail deuterated dPOPC.
As shown in Figure 2A, in the case of the saturated lipids
(dDMPC), ApoE4 presents a slightly stronger interaction with
Frontiers in Chemistry | www.frontiersin.org 5 April 2021 | Volume 9 | Article 630152
Waldie et al. ApoE-HDL Particles at Cellular Membranes
FIGURE 2 | ApoE interaction with saturated (dDMPC) or unsaturated (dPOPC) model membranes measured at 37◦C, in Tris-buffer at pH 7.4: kinetics of lipid
replacement in terms of the relevant change in solvent penetration of the lipid core, taking into account SLD change also, are given for ApoE3 and ApoE4 (A). Net lipid
removal calculated as the difference in solvent coverage within the bilayers before and after 6 h incubation with apolipoproteins (B) and volume fractions of protein
binding within the core (C) or on top of (D) the SLBs upon 6 h of incubation and rinsing with Tris buffer. The NR profiles and best fits are shown in the
Supplementary Figures 1, 2. *Statistically different assuming p = 0.1; **Statistically different assuming p = 0.05.
the lipids than ApoE3 in terms of lipid removal and lipid
replacement by protein adsorption (reflected by the solvent
change in the membrane core), whereas the opposite trend can
be observed for the unsaturated lipids (dPOPC). In terms of
kinetics, most of the binding to unsaturated membranes occurs
within the first hour of incubation for both ApoE isoforms
(Figure 2A). For saturated lipids, the two ApoE variants show
a slightly different behaviour. On one hand, ApoE3 shows a
similar initial pattern to that of unsaturated lipids but this is
followed by a slower increase, possibly suggesting a gradual and
slower removal of saturated lipids over longer time periods.
On the other hand, ApoE4 follows a more linear increase with
time. This implies a difference in the mode of interaction of
the proteins with the model membranes and this interaction
seems to be variant-dependent and sensitive to the level of
lipid saturation.
Following the incubation period, NR data were collected
using three isotopic contrasts to enable quantification of lipid
removal (calculated from change in solvent penetration), protein
binding to the membrane hydrophobic core and adsorption
on top of the membrane (Figures 2B–D). This additional 28
Å layer represents most of the compact protein in a lipid-free
state, allowing for some part to rearrange and integrate itself
into the bilayer (Chen et al., 2011). The main lipid-binding
region is the C-terminal (Li et al., 2003), thus it is possible that
the protein could rearrange itself to allow maximum binding
of lipids to this area. For membranes incubated with ApoE3,
few changes were required from the pristine membrane (lipid
bilayer) structure: the lipid head and tail thicknesses remained
constant, while there were minor changes in the lipid tail
SLD and both head and tail solvation. On the other hand,
interaction with ApoE4 required additional changes in the head
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and tail thicknesses to obtain better fits to the NR data. The
increased membrane modifications seen with both isoforms
correlate to the increased levels of embedded protein. When
looking at the net lipid removal (or increase in solvation) and
protein insertion (due to changes in SLD of the membrane
hydrophobic core) upon incubation with ApoE, both variants
showed a preference for the removal of saturated lipids rather
than unsaturated ones (Figure 2B). Lipids were removed and
replaced by protein insertion into the bilayer core (Figure 2C)
with more protein incorporation into unsaturated than saturated
membranes. The latter, in turn, indicates that the protein is
more prone to remain bound to the unsaturated membrane
without actually removing lipids. Additionally, a further protein
layer is formed on top of the SLB (Figure 2D). This layer has a
greater coverage, or protein volume fraction, for ApoE3 than for
ApoE4 regardless of membrane type. This indicates that ApoE3
preferentially interacts with the lipid headgroups compared to
ApoE4. Interestingly, and regardless of membrane type, the
protein fraction that binds to the lipid bilayer core is larger for
ApoE4 than ApoE3. Indeed, 70 and 76% of the ApoE4 protein
co-localised within the core of the saturated and unsaturated
membranes respectively, while these fractions decreased to 54
and 62% for ApoE3. NR can though not distinguish whether
it is the same protein stretching across the core and the
heads, or different individual proteins occupying either the
head or tail region in the SLB. In summary, even though
both ApoE variants displayed more binding to unsaturated
bilayers, the NR data highlight a difference between the variants.
In particular, the ApoE4 isoform binds to a larger extent to
the lipid core than the ApoE3 isoform and the conformation




rHDL made of ApoE and hDMPC were prepared using the
vesicle solubilisation approach and purified by size exclusion
chromatography (Figure 3A). The resulting rHDL particles were
structurally characterised by SANS in three isotopic contrasts
to highlight different parts of the particle and to increase the
accuracy of the fit (Figure 3B). For the fitting, the “nanodisc”
like structure model was adopted, which consists of an elliptical
bilayer encased by protein (inset of Figure 3A) and both fitted
and calculated values can be found in Table 2. These discs
resemble nascent HDL. HDL are mainly present in cerebrospinal
fluid but are also important for the clearance of lipids in the liver
via binding to ApoE receptors (Pitas et al., 1987).
The calculated values from Table 2 are determined as follows.
The equation used for circumference determination takes into
account the ellipticity of the particles as used previously (Skar-






+ (rmajor + dbelt)
2]/2 (1)
where rminor, dbelt and rmajor are the radius of the short axis,
the width of the protein belt and the radius of the major axis
respectively. This can be used for the determination of the
number of amino acids in contact with the bilayer by using
an average length per amino acid of 1.5 Å. With 299 residues
per ApoE molecule, this gives a maximum circumference of ∼
448 Å which is slightly larger than what was calculated here,
however leaves room for flexibility in the protein and possible
expansion. Previously reported data on related particles prepared
with similar proteins have also allowed for some residues to
not be in contact with the bilayer: about 20 amino acids per
protein were estimated not to be in direct contact with the
lipid core (Denisov et al., 2004; Skar-Gislinge et al., 2010).
The resulting area of the lipid bilayer region gives 139 lipid
molecules per leaflet for both ApoE3 and ApoE4, and each
disc contains two proteins, one per leaflet. This value is in
agreement with the one measured by phosphate analysis (145
and 151 lipids per leaflet for ApoE3 and ApoE4, respectively).
This number of lipids per leaflet agrees with data provided for
similar length apolipoprotein-like proteins (Bayburt and Sligar,
2010). The mean molecular area for the heads and tails was
calculated to be∼56 Å2 with∼30% hydration in the heads which
agrees well with the NR data presented and values found in
the literature (Bayburt and Sligar, 2010). The disc diameter is
larger compared to ApoA1 discs prepared in a similar manner
(Midtgaard et al., 2015); however, ApoE (34 kDa) is substantially
longer than ApoA1 (28 kDa) (Lund-Katz and Phillips, 2010),
thus resulting in larger discs. The diameter of the particles is
in agreement with dynamic light scattering data measured for
both ApoE3 and ApoE4 based discs which gave values between
10 and 15 nm prior to SANS measurements (results not shown).
Both ApoE3 and ApoE4 gave similar structured discs with the
same number of lipid molecules per leaflet and number of
proteins. This is not surprising due to the same protein length
and very similar sequence, only differing in one amino acid.
The main structural difference in the discs found between the
ApoE variants was the ellipticity, with ApoE3-rHDL being less
elliptical than ApoE4-rHDL. Finally, allowing the bilayer core
thickness to vary between a reasonable range did not significantly
improve the fit quality, thus it was kept fixed at 28 Å as it was
similar to the value seen with the NR. The use of atomic force
microscopy can also be beneficial to measure such thicknesses
(Bayburt and Sligar, 2002).
ApoE-Containing rHDL at Model
Membranes
As ApoE isoforms play different roles in the onset and
development of atherosclerosis and AD, with lipids found in
both atherosclerotic and AD plaques, we therefore used NR
to determine how the nascent-like rHDL of each isoform
behave in the exchange or removal of lipids. To this end,
ApoE-rHDL particles were incubated with model membranes
composed of dDMPC, in the absence or presence of cholesterol,
at 37◦C in Tris buffer at pH 7.4, and their interactions
were followed by NR (Figure 4). Both hydrogenous (h-
cholesterol) and deuterated cholesterol (d-cholesterol) were used
to determine whether ApoE particles specifically targeted the
cholesterol molecules.
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FIGURE 3 | Size exclusion chromatograms for ApoE3 and ApoE4 discs with inset of model used for fitting and negative stained TEM images for ApoE3-rHDL (A)
SANS data and best fits in three contrasts for the ApoE3- (B) and ApoE4-rHDL (C) measured at 25◦C in Tris buffer pH 7.4. The parameters used for the best fits
shown are listed in Table 2.
As shown in Figure 4A, there was little change in the surface
coverage of the model membrane upon interaction with ApoE-
rHDL as all SLBs started with at least 95% coverage and finished
with no less than 90% coverage. At similar protein concentration,
such small capacity for lipid removal cannot be compared
to mature HDL (purified from 3 male, healthy adult donors)
(Waldie et al., 2020), which can remove about 40% of the model
membrane (Waldie et al., 2020) in the absence of cholesterol.
This shows that, while some lipids were removed in certain cases,
lipid removal is not the main role of the ApoE nascent-like HDL.
HDL particles contain a large number of apolipoproteins (Maric
et al., 2019), with ApoA1 being the most abundant in serum.
Thus, the interaction of ApoA1-rHDL (also prepared by the
vesicle solubilisation method (Del Giudice et al., 2017a,b) with a
cholesterol containing saturated membrane was also investigated
(Del Giudice et al., 2017a,b). In the case of ApoA1-rHDL,
significant lipid removal occurred, though to a lesser extent than
mature HDL. Lipid removal was double for ApoA1-rHDL and
as much as five times for mature HDL as compared to ApoE-
rHDL samples. This suggests that more than just the increased
incubation time (ApoA1-rHDL and HDL were incubated for
8 h rather than 6 h) is at play. Additionally, kinetics of lipid
exchange show that equilibrium was reached after 6 h for ApoE3-
rHDL (Figure 4C) and ApoA1 (Supplementary Figure 5) while
continuous increase was observed for ApoE4-rHDL (Figure 4D),
regardless of membrane composition.
Lipid exchange (Figure 4B) is hereby defined as lipids
removed from the model membrane and replaced with lipids
from the rHDL particles, and is calculated from the SLD change
within the lipid tail region. In this case, a significant proportion
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TABLE 2 | Fitted and calculated parameters for the protein-DMPC particles.
Parameters ApoE3 ApoE4
Radius* Å 42.0 ± 0.4 38.1 ± 0.2
Ellipticity ratio* 1.4 1.7
Protein rim thickness* Å 11.0 ± 0.8 8.6 ± 0.3
Lipid headgroup thickness* Å 9.0 ± 0.1 9.0 ± 0.1
Bilayer core thickness*** Å 28 28
Short-long axis disc diameter** Å 106–139.6 93.4–146.7
Disc circumference** Å 389 386
No. amino acids** 260 258
Area per lipid** Å2 55.9 55.9
No. lipids per leaflet** 139 139
No. proteins per disc** 2 2
*Fitted values. **Calculated values. ***Fixed value.
of the lipids were exchanged by ApoE-rHDL and the extent of
which was similar regardless of the ApoE isoform present. In
the absence of cholesterol, 40.4 ± 0.5% and 37.2 ± 0.6% lipid
exchange occurred for ApoE3- and ApoE4-rHDL respectively.
However, in the presence of cholesterol, 30.0 ± 0.5% and 29.1
± 0.5% lipid exchange took place for ApoE3- and ApoE4-rHDL
respectively. Bearing in mind the difference in incubation time
(ApoE3-rHDL were incubated 2 h longer than ApoE4-rHDL, see
Figures 4C,D), this suggests that ApoE4-rHDL have the ability to
exchangemore lipids than ApoE3-rHDL. This is confirmed when
observing the quantities of lipids exchanged in the membranes
containing d-cholesterol for which the samples were incubated
for the same time period (6 h). In this case, the final exchange
values differ more drastically: 16.7 ± 0.8% and 25 ± 1% for
ApoE3 and ApoE4, respectively. The trend is clear that ApoE4-
rHDL exchanged more lipids than the ApoE3-rHDL regardless
of membrane composition. In Figure 4B, the extent of lipid
exchange for both ApoA1-rHDL and mature HDL upon 8 h
incubation has similar lipid exchange capacity to ApoE3-rHDL,
while ApoE4-rHDL has significantly greater affinity for lipid
exchange than any of the other samples tested.
To be able to determine if cholesterol was being preferentially
exchanged by either ApoE variant, both deuterated and non-
deuterated cholesterol were used. If cholesterol was exchanged
preferentially over the phospholipids, a net difference would be
seen in the final quantity of lipids exchanged across these two
membranes due to lack of contrast between h-cholesterol and
the hydrogenous lipids in the rHDL or mature HDL samples.
No difference was seen as shown in Figures 4C,D (dotted and
dashed lines), which suggests that the phospholipid molecules
were primarily exchanged rather than the cholesterol molecules.
Mirroring the NR data for protein incubation alone on
model membranes (Figure 2), the model membranes exposed
to ApoE4-rHDL required greater structural and compositional
changes to obtain a satisfactory fit to the experimental data.
Membranes exposed to ApoE3-rHDL were fitted with head and
tail region thicknesses kept constant, whereas ApoE3-rHDL on
dDMPC + d-cholesterol and all membranes exposed to ApoE4-
rHDL required changes to the head and tail thicknesses to find
suitable fits. All variations were tested: from keeping them all
the same, to only altering the head thickness or to varying
all regions. It was found that better fits were possible when
allowing greater variation when incubated with ApoE4-rHDL,
again indicating greater level of interaction occurring in the
presence of ApoE4 compared to ApoE3. This could in part be
due to slight embedding of ApoE4 into the hydrophobic core of
the membrane, although the resulting membranes were found
to maintain, within error, a constant area per molecule across
heads and tails. This suggests that the lipid bilayer structure
was retained in all cases, however it cannot be disregarded
that protein insertion could be balanced in the lipid heads and
tails in such a manner that the SLB structure holds. Finally,
similar levels of rHDL particles on top of the model membranes
were found regardless of ApoE isoform or bilayer composition
(approximately 1%).
DISCUSSION
While the structural difference between the ApoE isoforms is
subtle (Chou et al., 2005), clear differences can be seen in their
behaviour upon interaction with lipid bilayers. In particular,
ApoE4 binds to a larger extent to the membrane core than ApoE3
(Figure 2C), although about the same amount of protein sits on
top of themembrane regardless of the lipid type, for each isoform,
respectively (Figure 2D). These changes impact the ability of
ApoE to bind lipids. In particular, ApoE4 has a greater ability to
bind lipids due to structural differences in the helical segments
of the C-terminal. This difference leads to a reduced ability to
form tetramers, which are less capable than the monomer of
binding lipids (Garai et al., 2011; Chetty et al., 2017). ApoE4’s
increased affinity for lipid binding is also suggested by the fact
that ApoE4 preferentially binds to VLDL (for which its surface
is about 60% lipids) rather than HDL, whereas ApoE3 binds
preferentially to HDL (for which its surface is about 80% protein).
Furthermore, ApoE4 lacks flexibility in its C-terminal domain
leading to a preference for the lower curvature of the VLDL
particles (Hatters et al., 2005; Nguyen et al., 2010). The increased
affinity for VLDL leads to an increased clearance of VLDL from
plasma via ApoE receptors in the liver. However, this in turn
leads to LDL receptors being downregulated, raising overall levels
of plasma LDL and leading to an increased risk for atherosclerosis
(Dong and Weisgraber, 1996; Mahley, 2016a).
Here, we observed that most protein incorporation into
bilayers (Figure 2A) occurred within the first hour for the
unsaturated lipids but there was further increase with time
for saturated ones. Earlier reports on the rate of lipid binding
and vesicle solubilisation showed a biexponential decay when
solubilising DMPC vesicles at their melting temperature of 24◦C
(Segall et al., 2002), with ApoE4 presenting a higher rate constant
than ApoE3. Another study showed that ApoE4 displays an
increased ability to disrupt DMPC vesicles compared to ApoE3
by measuring the release of fluorescent dye (Ji et al., 2002).
Recently, our group showed that native HDL, through its
apolipoproteins, present a lower ability to exchange and replace
unsaturated lipids as compared to saturated ones (Waldie et al.,
Frontiers in Chemistry | www.frontiersin.org 9 April 2021 | Volume 9 | Article 630152
Waldie et al. ApoE-HDL Particles at Cellular Membranes
FIGURE 4 | Lipid removal (A) and lipid exchange (B) across model membranes for ApoE3- and ApoE4-rHDL. Three model membranes were used: saturated lipids
(dDMPC) in the absence or presence of hydrogenous or deuterated cholesterol. Data for mature HDL and ApoA1-rHDL against the cholesterol containing bilayers
(Waldie et al., 2020) are also included. The asterisk indicates an incubation time of 8 h compared to 6 h for those without. Kinetics of lipid exchange for rHDL
containing ApoE3 (C) and ApoE4 (D) in terms of the relative change in SLD of the solvated lipid core over time. HDL data is replotted from Haertlein et al. (2016). The
NR profiles and best fits are given in the Supplementary Figures 4, 5. All statistically different assuming p = 0.05 apart from dDMPC + hchol for lipid exchange (B).
2020). Both ApoE variants mirror this trend since these proteins
remove more saturated than unsaturated lipids. Atherogenic
and amyloid plaques are rich in saturated lipids and cholesterol
(Touboul and Gaudin, 2014; Kiskis et al., 2015). In a recent
study, a link between AD and the disruption of the metabolism of
unsaturated fats such as omega 3 was found, which could provide
an explanation for ApoE4’s higher affinity for the unsaturated
membrane (Snowden et al., 2017). Indeed, a previous report
states that supplementingmono- and poly-unsaturated fats in the
diet reduce the risk to AD, whereas the introduction of saturated
fats increase this risk (Morris, 2004).
The fact that a larger fraction of ApoE4 binds the lipid core
compared to ApoE3 and that it displays less sensitivity to the
lipid type in the membrane (Figures 2C,D) could be linked to
a decreased protein flexibility although NR cannot distinguish
whether different ApoE molecules bind to the core and the
head or if a single protein bends over across tails and heads.
Indeed, ApoE4’s greater rigidity forces it to maintain a more
compact conformation around the lipid core which, in turn,
could render it less able to bind to HDL. Earlier, ApoE4 was
shown to disrupt the lipid membrane to a larger extent than
ApoE3 (Mahley et al., 2009), in agreement with our results that
show larger ApoE4 incorporation into the bilayers and greater
structural changes in the SLBs required to fit the NR data
after protein incubation. Indeed, ApoE4 could retain a more
compact structure folded back on itself due to the Arg-61:Glu-
255 salt bridge that could restrain the protein’s structure even
when associated with lipids (Raussens et al., 1998; Drury and
Narayanaswami, 2005; Hatters et al., 2009).
Regarding the rHDL structure, the reports on ApoE-
containing particles mainly involve electron microscopy
and spectroscopic studies for structural determination
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(Narayanaswami et al., 2004; Newhouse et al., 2005); and
ultracentrifugation (Raussens et al., 1998) and native gel
electrophoresis (Raussens et al., 1998; Narayanaswami et al.,
2004) for size determination. These reports are in agreement
with the size of particles reported here: 10–15 nm in diameter
(Figure 3 and Table 2). Contrary to ApoE-rHDL, ApoA1-
or membrane scaffold protein (MSP)-based nanodiscs form
particles that are about 8–12 nm in diameter (Denisov et al.,
2004; Bayburt and Sligar, 2010; Skar-Gislinge et al., 2010; Del
Giudice et al., 2017a). A variety of models have been presented
to describe protein-lipid particles from the picket-fence model
(Jonas et al., 1989), to the double superhelix (Wu et al., 2009)
or double belt-like structure (Segrest et al., 1999; Midtgaard
et al., 2015), though some of these have faced opposition within
the nanodisc community (Jones et al., 2010; Gogonea, 2016).
Ellipticity is the main structural feature which differed between
the ApoE rHDL, with ApoE4 forming more elongated discs.
Our data agree well with the double belt structure since the data
suggest that there are two proteins present per nanodisc, also
in agreement with ApoA1-rHDL. Previously reported data on
ApoE-rHDL show the presence of two or more proteins per disc
(Raussens et al., 1998; Narayanaswami et al., 2004; Yamamoto
et al., 2008). There has been some debate as to whether ApoE3
and ApoE4 form nanodiscs in a different manner giving
structural differences to the protein conformation (de Chaves
and Narayanaswami, 2008) and, in turn, their lipid exchange
ability. The hypotheses suggested include ApoE3 forming more
of an extended belt conformation around the whole perimeter of
the disc due to increased flexibility (Narayanaswami et al., 2004).
The more compact structure of ApoE4 could lead to potentially
more ApoE4 molecules per nanodisc compared to ApoE3 (Gong
et al., 2002). However, the same number of molecules were found
to be present in both nanodisc variants presented here. The NR
lipid exchange data (Figure 4), on the other hand, suggest that
the proteins adapt slightly different conformations giving rise to
their differing exchange capabilities.
Where some reports have shown an incremental size increase
of nanodiscs with increasing protein length (Denisov et al., 2004,
2005), it is of no surprise that the ApoE-rHDL particles reported
here are of a slightly larger size than previously reported for
ApoA1-rHDL, as the ApoE protein is longer. In turn, the number
of lipid molecules per nanodisc is also higher for ApoE- than
ApoA1-containing nanodiscs which does not seem to have an
effect on the ability of these nanodiscs to exchange lipids: the
similar size of ApoE3- and ApoE4-rHDL does not translate into
similar functional capabilities, as clear differences were observed
in their lipid exchange and removal affinity (Figures 4A,B).
Moreover, the lipid exchange (Figure 4B) was similar between
ApoE3- and ApoA1-rHDL while it was different between ApoE
isoforms, despite them being of similar size but larger than
ApoA1 (since the nanodisc concentration was constant across
samples, smaller discs imply lower lipid concentration in the case
of ApoA1). Therefore, it is clear that the rHDL size (area of the
lipid nanodisc) does not determine the extent of lipid exchange;
rather, specific apolipoprotein-lipid interactions must be behind
the observed phenomena.
ApoA1 and ApoE have similar structures comprising
amphipathic alpha-helices that enable them to form nascent
HDL-like structures by solubilising phospholipids (Lund-Katz
and Phillips, 2010). However, neither ApoE3 nor ApoE4 remove
further lipids from the membrane than those exchanged, to
a significant degree. This contrasts from what is observed for
ApoA1-rHDL, which instead remove a notable quantity of lipids,
although to a lesser extent than mature HDL (Figure 4A). The
results obtained for ApoA1 are not surprising since it is the
more abundant serum HDL protein, whose function is to clear
lipids. Our results suggest that the function of ApoE cannot
be mainly related to the lipid exchange, but rather to binding
ApoE-receptors in the liver. Indeed, the fact that the structure of
ApoE4 is more compact than ApoE3 might affect how it binds to
ApoE- and other LDL receptors in the liver (Ruiz et al., 2005).
However, ApoE-HDL serve as the primary brain lipoproteins,
being produced there and lacking the ability to cross the blood-
brain barrier (Pitas et al., 1987). The ApoE in the brain is the
second most abundant place for ApoE production in the body
after the liver (Mahley, 2016a). ApoE plays an important role
in maintaining the homeostasis of cholesterol concentration in
the brain, where this lipid comprises about 20–25% of the body’s
total cholesterol (Michikawa, 2006). Whilst HDL in the rest
of the body participate in cholesterol efflux thereby removing
cholesterol from artery walls, ApoE-HDL in the brain maintain
constant cholesterol levels (Mahley, 2016b). Indeed, the current
data clearly show that lipid exchange was not affected by the
level of deuteration in cholesterol (Figure 4), suggesting that
ApoE does not interact with cholesterol significantly. Instead,
these results suggest that ApoE-enriched HDL rather transport
saturated lipids over cholesterol and unsaturated lipids. By
regulating the ratio of saturated lipids in cellular membranes,
ApoE-HDL may help maintain membrane elasticity, which is
key for the healthy function of the cell. Interestingly, cholesterol
crystal nucleation starts sooner in unsaturated than saturated
model biles (Halpern et al., 1993), which suggests a higher free
cholesterol concentration is achieved in membranes comprised
of saturated lipids. Thus, ApoE4 can potentially favour an
increase in membrane saturation with cholesterol by exchanging
and removing more saturated fats than ApoE3, which could
potentially lead to cholesterol crystallisation in the brain.
Even though ApoE4 has a higher affinity to bind lipids than
ApoE3 as demonstrated here and elsewhere (Saito et al., 2003),
the ability of ApoE isoforms to catalyse the efflux of cholesterol
has been disputed: some studies conclude the process is not ApoE
isoform dependent (Krimbou et al., 2004) while others have
found that ApoE4 has a lesser ability to perform cholesterol efflux
compared to ApoE3, especially in relation to neurons in the brain
(Huang et al., 1995; Gong et al., 2002; Michikawa et al., 2007).
This lack of ability of ApoE4 to remove and deposit cholesterol
in the brain efficiently has been proposed to be one of the main
reasons for the onset of AD (Gong et al., 2002; de Chaves and
Narayanaswami, 2008). Our simplified model shows that neither
ApoE isoform has a special affinity for taking up cholesterol and
it is therefore hypothesised that there is no significant difference
in their capacity to efflux cholesterol.
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CONCLUSIONS
Neutron reflection results suggest that ApoE4 adopts a different
conformation to ApoE3 at model membranes, and that
this conformation differs between saturated and unsaturated
membranes for ApoE3 only. Moreover, neither ApoE isoform
removes a significant amount of unsaturated lipids from the
model membrane used but they were able to remove saturated
lipids to similar extents. Small-angle neutron scattering was
used to demonstrate that the structure of nascent-like rHDL
particles made with DMPC and either ApoE3 or ApoE4 is similar,
forming elliptical disc-like structures. Neutron reflection was
then used to quantify the extent of lipid exchange and lipid
removal by nascent-like rHDL particles and model membranes.
The data show that either ApoE3- or ApoE4-rHDL particles
have a low ability to remove saturated lipids as compared to
ApoA1-rHDL or mature HDL. The extent of lipid exchange,
on the other hand, is similar between the isoforms and is
impaired by the presence of cholesterol. Finally, ApoE does
not exchange or remove cholesterol molecules but rather
saturated lipids. The results here mirror the physiological roles
of ApoE-HDL and ApoA1-HDL particles in the brain and
in serum respectively. This demonstrates that our models are
suitable to study the function of these particles in a range of
experimental conditions.
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